Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cusi

Showing results (21-30 of 189) with videos related to

Pageof 19
Sort By:
Clinical Diabetes and Endocrinology|July 14, 2017
Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes MellitusPaola Portillo-Sanchez, Kenneth Cusi
Diabetes Spectrum : a Publication of the American Diabetes Association|February 22, 2024
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient CareJuan Patricio Nogueira, Kenneth Cusi
Diabetes Care|April 20, 2026
Integrating Alcohol Use Into MASLD Care: A Practical Guide for Diabetes and Obesity Care TeamsAnastasia-Stefania Alexopoulos, Kenneth Cusi
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD)Romina Lomonaco, Janet Chen, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|July 6, 2023
Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of HyperglycemiaJuan M Munoz Pena, Kenneth Cusi
Cardiovascular Diabetology|February 18, 2010
Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjectsManoj Mathew, Eric Tay, Kenneth Cusi
Clinics in Liver Disease|April 6, 2023
Metabolic Syndrome and Its Association with Nonalcoholic SteatohepatitisFernando Bril, Arun Sanyal, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|October 28, 2022
Approach to the Patient With Nonalcoholic Fatty Liver DiseaseRenata Belfort-DeAguiar, Romina Lomonaco, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|August 18, 2021
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLDChandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala
Metabolism: Clinical and Experimental|June 16, 2016
Pharmacological management of nonalcoholic fatty liver diseaseDiana Barb, Paola Portillo-Sanchez, Kenneth Cusi
Pageof 19

Showing results (21-30 of 189) with videos related to

Sort By:
Pageof 19
Clinical Diabetes and Endocrinology|July 14, 2017
Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes MellitusPaola Portillo-Sanchez, Kenneth Cusi
Diabetes Spectrum : a Publication of the American Diabetes Association|February 22, 2024
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient CareJuan Patricio Nogueira, Kenneth Cusi
Diabetes Care|April 20, 2026
Integrating Alcohol Use Into MASLD Care: A Practical Guide for Diabetes and Obesity Care TeamsAnastasia-Stefania Alexopoulos, Kenneth Cusi
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD)Romina Lomonaco, Janet Chen, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|July 6, 2023
Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of HyperglycemiaJuan M Munoz Pena, Kenneth Cusi
Cardiovascular Diabetology|February 18, 2010
Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjectsManoj Mathew, Eric Tay, Kenneth Cusi
Clinics in Liver Disease|April 6, 2023
Metabolic Syndrome and Its Association with Nonalcoholic SteatohepatitisFernando Bril, Arun Sanyal, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|October 28, 2022
Approach to the Patient With Nonalcoholic Fatty Liver DiseaseRenata Belfort-DeAguiar, Romina Lomonaco, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|August 18, 2021
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLDChandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala
Metabolism: Clinical and Experimental|June 16, 2016
Pharmacological management of nonalcoholic fatty liver diseaseDiana Barb, Paola Portillo-Sanchez, Kenneth Cusi
Pageof 19